Acylation-stimulatory activity in hyperapobetalipoproteinemic fibroblasts: enhanced cholesterol esterification with another serum basic protein, BP II - PubMed (original) (raw)
Acylation-stimulatory activity in hyperapobetalipoproteinemic fibroblasts: enhanced cholesterol esterification with another serum basic protein, BP II
P Kwiterovich Jr et al. Proc Natl Acad Sci U S A. 1990 Nov.
Abstract
Cultured fibroblasts from patients with familial hyperapobetalipoproteinemia (hyperapoB) were used to determine if a defect in lipid metabolism was present. Three basic proteins (BP I, BP II, and BP III) were isolated from normal human serum by preparative isoelectric focusing, preparative SDS/PAGE, and reversed-phase HPLC. The Mr and pI values of these proteins were 14,000 and 9.10 for BP I, 27,500 and 8.48 for BP II, and 55,000 and 8.73 for BP III. These proteins differed significantly in their content of arginine, cysteine, proline, histidine, serine, and methionine. BP I appears to be the same protein as acylation-stimulating protein, but BP II and BP III appeared different from acylation-stimulating protein and other lipid carrier proteins. BP I, BP II, and BP III stimulated the incorporation of [14C]oleate into lipid esters in normal fibroblasts, an effect that was time and concentration dependent. In hyperapoB cells, BP II markedly increased (up to 9-fold) the incorporation of [14C]oleate into cholesteryl ester compared with that in normal cells; in addition, there was a 50% decrease in the stimulation of triglyceride acylation and cholesterol esterification with BP I. No difference between normal and hyperapoB cells was observed with BP III. In summary, the identification of another serum basic protein, BP II, led to the elucidation of another cellular defect in hyperapoB fibroblasts, enhanced cholesterol esterification, which may be related to the precocious atherosclerosis and abnormal lipoprotein metabolism seen in hyperapoB.
Similar articles
- The effect of three serum basic proteins on the mass of lipids in normal and hyperapoB fibroblasts.
Kwiterovich PO Jr, Motevalli M, Miller M. Kwiterovich PO Jr, et al. Arterioscler Thromb. 1994 Jan;14(1):1-7. doi: 10.1161/01.atv.14.1.1. Arterioscler Thromb. 1994. PMID: 8274464 - Further insights into the pathophysiology of hyperapobetalipoproteinemia: role of basic proteins I, II, III.
Kwiterovich PO Jr, Motevalli M, Miller M, Bachorik PS, Kafonek SD, Chatterjee S, Beaty T, Virgil D. Kwiterovich PO Jr, et al. Clin Chem. 1991 Mar;37(3):317-26. Clin Chem. 1991. PMID: 2004437 Review. - Differential effect of genistein on the stimulation of cholesterol production by basic protein II in normal and hyperapoB fibroblasts.
Kwiterovich PO Jr, Motevalli M. Kwiterovich PO Jr, et al. Arterioscler Thromb Vasc Biol. 1998 Jan;18(1):57-64. doi: 10.1161/01.atv.18.1.57. Arterioscler Thromb Vasc Biol. 1998. PMID: 9445257 - Abnormal protein tyrosine phosphorylation in fibroblasts from hyperapobetalipoproteinemia subjects.
Motevalli M, Goldschmidt-Clermont PJ, Virgil D, Kwiterovich PO Jr. Motevalli M, et al. J Biol Chem. 1997 Sep 26;272(39):24703-9. doi: 10.1074/jbc.272.39.24703. J Biol Chem. 1997. PMID: 9305942 - A critical evaluation of the putative role of C3adesArg (ASP) in lipid metabolism and hyperapobetalipoproteinemia.
Kildsgaard J, Zsigmond E, Chan L, Wetsel RA. Kildsgaard J, et al. Mol Immunol. 1999 Sep-Oct;36(13-14):869-76. doi: 10.1016/s0161-5890(99)00108-x. Mol Immunol. 1999. PMID: 10698341 Review.
Cited by
- The adipsin-acylation stimulating protein system and regulation of intracellular triglyceride synthesis.
Baldo A, Sniderman AD, St-Luce S, Avramoglu RK, Maslowska M, Hoang B, Monge JC, Bell A, Mulay S, Cianflone K. Baldo A, et al. J Clin Invest. 1993 Sep;92(3):1543-7. doi: 10.1172/JCI116733. J Clin Invest. 1993. PMID: 8376604 Free PMC article. - Incorporation of oleic acid and eicosapentaenoic acid into glycerolipids of cultured normal human fibroblasts.
Miller M, Motevalli M, Westphal D, Kwiterovich PO Jr. Miller M, et al. Lipids. 1993 Jan;28(1):1-5. doi: 10.1007/BF02536351. Lipids. 1993. PMID: 8446005
References
- Nature. 1970 Aug 15;227(5259):680-5 - PubMed
- Am J Cardiol. 1985 Feb 1;55(4):291-5 - PubMed
- Proc Natl Acad Sci U S A. 1980 Jan;77(1):604-8 - PubMed
- J Chromatogr. 1984 Dec 7;336(1):93-104 - PubMed
- J Clin Invest. 1986 Mar;77(3):663-72 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous